Quantcast
Last updated on April 18, 2014 at 14:37 EDT

Latest Pemetrexed Stories

2014-04-10 23:24:17

Mexican researchers say an alternative to the standard mesothelioma chemotherapy regimen can not only improve survival and quality of life, but can also save money. Raleigh, NC (PRWEB) April 10, 2014 Scientists in the Thoracic Oncology Unit at Mexico’s National Cancer Institute say continuous infusions of low-dose Gemzar (gemcitabine) with cisplatin appear to be a safe and effective alternative to standard mesothelioma chemotherapy. Click here to read about the new study on the...

2014-04-01 23:26:52

Italian researchers say a drug used to treat breast cancer appears to shrink mesothelioma tumors, too. Raleigh, NC (PRWEB) April 01, 2014 The breast cancer drug Aromasin may offer a new way to treat malignant pleural mesothelioma, according to research conducted at Italy. Click here to read details of the new study, available now on the Surviving Mesothelioma website. Cancer researchers with Regina Elena National Cancer Institute in Rome have concluded that the drug Aromasin...

2014-03-31 20:22:46

INDIANAPOLIS, March 31, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. District Court for the Southern District of Indiana has ruled in the company's favor regarding the vitamin dosage regimen patent for Alimta(®) (pemetrexed for injection). In the case of Eli Lilly and Company v. Teva Parenteral Medicines Inc., et al., the court ruled the vitamin dosage regimen patent is valid and enforceable. The patent provides intellectual property protection...

2014-03-28 12:21:55

DUBLIN, Mar. 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/cvsjq3/investigation ) has announced the addition of the "Investigation Report on China Pemetrexed Market, 2009-2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Pemetrexed, originally developed by Eli Lilly and Company, is a multi-targeted antimetabolite antitumor drug. This product is with huge growth potential in the market. Approved by FDA...

2014-03-27 12:30:55

A St. Jude Children's Research Hospital-led study identified two adult cancer drugs with potential to improve treatment of a high-risk childhood brain tumor; the drugs are now part of a pediatric clinical trial MEMPHIS, Tenn., March 27, 2014 /PRNewswire-USNewswire/ -- The quest to improve survival of children with a high-risk brain tumor has led St. Jude Children's Research Hospital investigators to two drugs already used to treat adults with breast, pancreatic, lung and other...

2014-03-24 23:24:12

Japanese researchers say the drug Alimta (pemetrexed) in combination with cisplatin should remain the top first-line treatment for malignant pleural mesothelioma. Raleigh, NC (PRWEB) March 24, 2014 Japanese researchers say the drug Alimta (pemetrexed) in combination with cisplatin should remain the top first-line treatment for malignant pleural mesothelioma. Their findings have just been posted by Surviving Mesothelioma at...

2014-02-19 08:31:13

-- Ramucirumab Improved Survival in Second-Line Study of Patients with Non-Small Cell Lung Cancer -- INDIANAPOLIS, Feb. 19, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the REVEL trial, a global Phase III study of ramucirumab in combination with chemotherapy in patients with second-line non-small cell lung cancer (NSCLC), showed a statistically significant improvement in the primary endpoint of overall survival in the ramucirumab-plus-docetaxel arm...

2014-01-16 23:24:20

Researchers recommend that drug choice be guided by aspects of the patient’s condition. Raleigh, NC (PRWEB) January 16, 2014 Surviving Mesothelioma is reporting on newly published research suggesting that certain aspects of a peritoneal mesothelioma patient’s condition may have an impact on the toxicity of chemotherapy. A combination of pemetrexed (Alimta) and a platinum-based drug like cisplatin or carboplatin is the drug treatment of choice for patients with pleural mesothelioma,...

2014-01-04 23:01:12

Scientists in Japan and Austria say the kinase inhibitor temsirolimus stops mesothelioma growth in two different ways. Raleigh, NC (PRWEB) January 04, 2014 A new study published in the journal Oncology Reports and detailed by Surviving Mesothelioma suggests that temsirolimus, a kinase inhibitor used to treat advanced renal cell carcinoma (RCC), may offer a promising new way to treat malignant pleural mesothelioma. The group studied temsirolimus by itself and in combination with the...

2014-01-02 23:25:36

Australian researchers say bromelain may be the key to making chemotherapy more effective for mesothelioma patients. Raleigh, NC (PRWEB) January 02, 2014 A study conducted in Australia and reported by Surviving Mesothelioma finds that a compound derived from the stems of pineapples appears to be able to improve standard drug treatment for peritoneal mesothelioma. Bromelain has a history of use in folk medicine and is believed to have anti-inflammatory effects.Previous studies have found...